Clinical Cancer Research Grants Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyata, H.
Right arrow Articles by Monden, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyata, H.
Right arrow Articles by Monden, M.
Clinical Cancer Research Vol. 6, 4859-4865, December 2000
© 2000 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

CDC25B and p53 Are Independently Implicated in Radiation Sensitivity for Human Esophageal Cancers1

Hiroshi Miyata, Yuichiro Doki2, Hitoshi Shiozaki, Msatoshi Inoue, Msahiko Yano, Yoshiyuki Fujiwara, Hirofumi Yamamoto, Kiyonori Nishioka, Kentaro Kishi and Morito Monden

Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Osaka 565-0871 Japan

Ionized radiation leads to G1 arrest and apoptosis by a p53-dependent pathway and G2-M arrest through a p53-independent pathway. In this study, we evaluated the role of cell cycle-regulating molecules in the sensitivity of cancer cells for radiation therapy. Forty-seven patients with squamous cell carcinomas of the esophagus had undergone radiation therapy, followed by surgical resection. They were classified as sensitive to radiation (SR, 14 cases) with no residual tumor in the surgical specimen or as resistant to radiation (RR, 33 cases) with viable residual tumors. Their preradiation biopsy samples were immunohistochemically investigated for the expressions of cell cycle-related molecules, including p53, CDC25A, CDC25B, cyclin D1, cyclin B1, and Ki-67. p53 expression was negative in 71% (10 of 14) of SR and positive in 91% (30 of 33) of RR. The association was strong between high radiation sensitivity and negative p53 expression (P < 0.0001). CDC25B, which is not expressed in normal epithelium but is in the cytoplasm of esophageal cancers, was strongly expressed (2+) in 46% (6 of 14) of SR and in 6% (2 of 23) of RR. Thus, the sensitivity for radiation therapy was significantly correlated with CDC25B overexpression. With respect to CDC25A, cyclin D1, cyclin B1, and Ki-67, no statistically significant differences were found in their expressions between SR and RR tumors. p53 and CDC25B expressions showed no significant associations, and multivariate analysis revealed that both p53 and CDC25B are significant independent markers for predicting radiation sensitivity. CDC25B was revealed to be a novel predictor of radiation sensitivity in esophageal cancers. Because CDC25B is an oncogene, which affects G2-M progression, these results suggest the importance of a p53-independent G2-M checkpoint in radiation therapy.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Varmeh and J. J. Manfredi
Inappropriate Activation of Cyclin-dependent Kinases by the Phosphatase Cdc25b Results in Premature Mitotic Entry and Triggers a p53-dependent Checkpoint
J. Biol. Chem., April 3, 2009; 284(14): 9475 - 9488.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J.-Z. Shou, N. Hu, M. Takikita, M. J. Roth, L. L. Johnson, C. Giffen, Q.-H. Wang, C. Wang, Y. Wang, H. Su, et al.
Overexpression of CDC25B and LAMC2 mRNA and Protein in Esophageal Squamous Cell Carcinomas and Premalignant Lesions in Subjects from a High-Risk Population in China
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1424 - 1435.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
K. Hayashi, S. Motoyama, T. Sugiyama, J.-i. Izumi, A. Anbai, H. Nanjo, H. Watanabe, K. Maruyama, Y. Minamiya, S. Koyota, et al.
REG I{alpha} is a Reliable Marker of Chemoradiosensitivity in Squamous Cell Esophageal Cancer Patients
Ann. Surg. Oncol., April 1, 2008; 15(4): 1224 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
S.-C. Zhang, S.-i. Miyamoto, T. Kamijo, R. Hayashi, T. Hasebe, G. Ishii, M. Fukayama, and A. Ochiai
Intratumor Microvessel Density in Biopsy Specimens Predicts Local Response of Hypopharyngeal Cancer to Radiotherapy
Jpn. J. Clin. Oncol., December 1, 2003; 33(12): 613 - 619.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Kishi, Y. Doki, M. Yano, T. Yasuda, Y. Fujiwara, S. Takiguchi, S. Kim, I. Higuchi, and M. Monden
Reduced MLH1 Expression after Chemotherapy Is an Indicator for Poor Prognosis in Esophageal Cancers
Clin. Cancer Res., October 1, 2003; 9(12): 4368 - 4375.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Miyata, Y. Doki, H. Yamamoto, K. Kishi, H. Takemoto, Y. Fujiwara, T. Yasuda, M. Yano, M. Inoue, H. Shiozaki, et al.
Overexpression of CDC25B Overrides Radiation-induced G2-M Arrest and Results in Increased Apoptosis in Esophageal Cancer Cells
Cancer Res., April 1, 2001; 61(7): 3188 - 3193.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.